# Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist

> **Open Intelligence Dossier** · First detected: 2026-10-29 16:40 UTC · Category: Business

## Executive Summary
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
&quot;Iovance, A Top 1% Biotech Stock, Crashes In A Surprise Lung Cancer Twist&quot; is generating significant coverage in the Business category, with 6 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Yahoo Finance, Trefis, Seeking Alpha and Investing.com. PULSE measures a story&#039;s velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE&#039;s extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| TIKR.com | Iovance Sinks Another 11% as Baird Cuts Target to $9 After Lung Cancer Data | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxPUHVzRnU5ZGd0WHNRRTc0ZjN3aklvZ092RExsZDJMQnI3TDdSTmNLSjdZSloxLWJkZTYycW55RU82MGdDLWtSYnNIYzJjTGhHZWVEYmFCVmlsOTV5SU05Q0hRQ0JIaUdxbTVrbmNZUWRFcVNMR2Z4ZGhhOFprNGwyS2dodjRCU1A1cndKbnA4M19ZSFhDclNZMDhwYU1OcFB4?oc=5) |
| The ASCO Post | TIL Therapy Plus Pembrolizumab for Advanced Melanoma | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxPLTY1eExiQkhnSlowZWRaUGtfUUhOdEJ6VG90a0lnX3c2Zlh3dVZLdmpqbDVzSUd6RzNuaEF6MzRpUEdWa01ody1uZWZTcDZQb0NnaXVFZUpRN2N6b3B4dFZ6a3lYamk3al82b21WSE1fVUVLdmF0VldleHROcWx2UEJyREZBRFlmNXI2ZXRQTkpaSkMyV0dv?oc=5) |
| GenomeWeb | Iovance Eyeing Biomarker-Informed Lung Cancer as Next Amtagvi Indication | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxOSU1PVUJGUU9nY1NOTmVJN2lqRE9qM3lvMHIzZHd2eUJid1hPR2g4bzlzSGktcGRnNW9HX1QwSkVpSVJ0WjZCV3V5WEd1WG1vZWxPNlJjT3hUckkyNGFIMWcxQlJlMzZnejRaeWVhcmZBdEdiRjVJdmRSYXhwSkxib05nMzV1RVdkZXpDTVZpUlNrN2lRRVBRUnVtVQ?oc=5) |
| Trefis | Is 50% Crash Risk For Iovance Stock Real? | [Source Link](https://news.google.com/rss/articles/CBMiogFBVV95cUxPM204U3NUelN2QnRNR0VWT3pUQjhicmF0bDZaWW1tWEtNZTZUOXZzMDFvekRQSzBEUlJfV25RNGVIZ0ZydFdrMVhLS1l3YXU4ckRqaUpvNHR5WGx4SDZKZlNBUjhCVlVJZFR2TExtVEhhMjZ2eWZ5QTE5c1R2cVprRHpCMDVWa3lIS09WWVFabFdaZUdKb2RfY1ZKZjJHdDlQR3c?oc=5) |
| Investing.com | Iovance stock falls after lung cancer trial data disappoints | [Source Link](https://news.google.com/rss/articles/CBMiuAFBVV95cUxPcVpiR2pycUk5M3V5UHBuYzZBdzlfMGFnQTBRR2R1WjlYQlRJYnBuemlQOU5pWVVWX1hyRmVKTFdCcDEyeHBiTTJweF9VWjNoNUl5NjNWQm5ITFdzOEtmTEs5OXd3YjBjbDR5TlE4LW9BaVdSN0s1cHd3N3dWbXdzQmxyWXBVLXMtODAtcEdfMldtOTV4eEVEQmg5Y3RiQi1LOFN6X3NEMWIzMnAtV0NDVGpMWXBROVhI?oc=5) |
| Yahoo Finance | Iovance Biotherapeutics (IOVA) Posts 59.1% Response In Lifileucel Lung Cancer Study | [Source Link](https://news.google.com/rss/articles/CBMinwFBVV95cUxOTGtzdTkySEZMSDF4bnNPdlkwZ0MyRjlGVnhTaW9vdkxjaVJKLU1FajlGbV9Zel9pT0dCUlBUOExXMldPYkhINXJ5UXMyYV9tWmtHMWNwSkx6OGVnREZ1SnVPRUJMSlZFRWFaXzhOS3c5NlF1RElZY0wzVGhQdTAtU0FJdUdnTVRGSUV1a0pvU3FJWmt5eGJfcFlYMGhMSjg?oc=5) |
| TIKR.com | Iovance Sinks 31% as Lung Cancer TIL Data Comes In “Consistent With Previously Reported Results” | [Source Link](https://news.google.com/rss/articles/CBMiuwFBVV95cUxPdEFSTVFoMG5UNnBEX0lrSjhmOUpMakFCeTM0cmc3VmpLT1FXRWZFZzZhVDFPMFZwVzN3T2Vna3NnWDJ4MUh0cEppX05obXVOQjc5cEpUaXFaZHBKbXhRN0RuWXNvbTVCaW1LR2RjY0dIemNTLXRWUmU0d2VYbXliMlZISjRCUVlYWUd1WWtaSWttZkZpa1hjdEVVZjBZb09Cc3V6THd1eUVXal9iMVE3aDB3TDNNeEs2QlNN?oc=5) |
| GlobeNewswire | Iovance Biotherapeutics to Host Webcast on Positive Data for TIL Therapy in Metastatic Non-Small Cell Lung Cancer (mNSCLC) and Broader Precision Medicine Strategy | [Source Link](https://news.google.com/rss/articles/CBMi0gJBVV95cUxORUtHS2pqeGpnWlFNSkVpMFlqUnNYSnhFeW5QMEZUNUh4RTVtNEtXem9RY0R4MzV1N3MzWnYza1pEV05IcTZYRjMyUTFaOWo0RE5Vb2tUOVhhbXZ6YThFQWR0OTVSV0pRVFVla2d5My1GYVpuRkJQakluVzZ1WEJtVVoxVl9wQ2lNUkdvMFhURjhkaDRlSC03UC1PaXVEWlZkaGVDcldOMW13X1FfUWhhdWJ6Wkc1bVg0SVk2TEZSTVE1ZUpTWmJKYjVKS2Q0M2taNW5fMjhRSFFVeEd4UnZaV3VjVXJNUi05anpPTEZCSW9QMnhhMEZteWJ2OG5DNnpLOEJUSURxOWFmZDM1RHJDaUhnUkp6ZEtLR2g1WlJuRnZ0LTVTdU4ydzFSQjJaU0RROVo0MnI4cGR0RnJndkJEUmhFNFlVYUIyU25vNlhldmJrZw?oc=5) |
| Seeking Alpha | Iovance plummets on new phase 2 Amtagvi data for non-small-cell lung cancer | [Source Link](https://news.google.com/rss/articles/CBMiqgFBVV95cUxObzJwaVI1OWk3RHUySEM5aFNnSnhBMjUzWnJhWmJJRmJuVndzVWNiQTRZeUNJeWNiR1pPaG9YN25jZVJ2WG9aQkYwdU1lZE5yMUlnQUFsZDczdlpKX3p6SExqU19ZS2RIMEZGZENqNE1GVU12cVhPeTlSdEdWeGE0bWFHWFNZUldYVlVoWTJwYlA1VVc2UWdwRE1MaXU5SnJXS0h1SjBVdWRoUQ?oc=5) |
| Yahoo Finance | Melanoma Trial Results Could Be A Game Changer For Iovance Biotherapeutics (IOVA) | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxOSlVDeHJBQ1B6aHBwRVU3VEl4Z3lDZGFTSk02OEMyTkNiWkRFTzlXamFPMUZfVnkzbzBPcTdNYnhLZThqVFJwc3duY01xS1diVXlJbnA1Q3dadmVqQzRnMW9haEw3YlZTa1dXM2JFeC15akYtVTN5enUxV1VZczhxMFFfR0tCSEFVUTdsODJEczh1VWNGT3RGTUVn?oc=5) |
| TradingView | Why Did IOVA Stock Jump Over 10% After-Hours Today? | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxPdWtqZ2RMZ1lybV9SSzQ4bER2cjNmYVZfeE1SUlVsOFJENE96VkdJMElJekdNSTFIeGZBY1BJVm5pUnNYSF9WQU1vSTliYW9Pb3VZNnpmbEs0a0R5aVNCUHRHdWhfNVRua3NweURadFl5SFp0dzR4a1hYcU00RTJWcnlrNGgxVTEzdUFDRWpWNVNHUjhrOUJXYTdXbjAySlNzMXRDRWlDckhrSjJyTWVj?oc=5) |
| Yahoo Finance | Why Did IOVA Stock Jump Over 10% After-Hours Today? | [Source Link](https://news.google.com/rss/articles/CBMikgFBVV95cUxOQ2lpUUQzYTJNM2p3blJBeXA0MW90TXpNWG0wejFJa181ZFdSZjBHWXA4NW1vbEljVUc1ZGZqbE9sNFEwUGM2cjBoRkh0VllpQ2dVRGxwd2ZVS1l1bHBwdFprRVlUQXNDQjF5cUxhTjE0Y05iX1QySC1BeTNkMDlseS1GckJTdFpvMWRUTWxvSHhBUQ?oc=5) |
| Yahoo Finance | Iovance stock falls after lung cancer trial data disappoints | [Source Link](https://news.google.com/rss/articles/CBMinAFBVV95cUxQRU1JbjI2RkZRckQyVTR0TXJ0UFJ2WU9qQmxTY3kzd1JCYmNVakJIeVdxTG9NcVdDUGRhUkhQLUIyaUNmLUJXMUVPS0hOTlU1NlVYbTNBMGY3UUhYZzRhcUltTkdyY0Zyc0ZTNUREUndCSXRLemMxQnhLbWxmbkc1Q0cyQ0l0ZjJPUHhyWlA1QnRTaGhqSFFnQ3VfWVg?oc=5) |
| Trefis | Can Iovance Stock Fall 50%? | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxPWGhXUlFlRTIzRzZlcUZKOVJ0QkwxV1ZCSG1TS2hvZEwzSHhEUmc3XzNzWG9SUjBjUGoxRlVjWmVKWUlQRWE4RmxzQ1BmaTRCbHJKNk4zWWx6UW9hZW1ScUZjRnlVRGR0dk9uX3VtNFZHV290eGZCQ1hMUUd4d09HRFNvdUxMc19IbEtaeWJiRQ?oc=5) |
| Seeking Alpha | Iovance sees long-term response for Amtagvi in first-line melanoma (IOVA:NASDAQ) | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxPNWVpLW5nRWMtVVpDSmoyektEcWtrUE0tdFB2SFRKUmc5bW90eGpGYjBwRUFBVTk4NGRadXNkQm5lNVludFBUSHBWbGF6MnNHQk5yTzV6U0dZMXo4SEQwSFRPY3VJbTQ5V3BzNDdjRXliellfTDFkR1k5ZE5qd0RBRlJKUU1qQ3d0LUJ0ai1qU0pLVnoxMms1a2p0QzJ0UQ?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-10-29/iovance-a-top-1-biotech-stock-crashes-in-a-surprise-lung-cancer-twist*
